RenovaCare Valuation
| RCAR Stock | USD 0.0001 0.00 0.00% |
RenovaCare seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of RenovaCare from analyzing the company fundamentals such as Price To Earning of (85.28) X, shares outstanding of 87.35 M, and Return On Equity of -5.69 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that RenovaCare's price fluctuation is very steady at this time. Calculation of the real value of RenovaCare is based on 3 months time horizon. Increasing RenovaCare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the RenovaCare pink sheet is determined by what a typical buyer is willing to pay for full or partial control of RenovaCare. Since RenovaCare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of RenovaCare Pink Sheet. However, RenovaCare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of RenovaCare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence RenovaCare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of RenovaCare helps investors to forecast how RenovaCare pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of RenovaCare more accurately as focusing exclusively on RenovaCare's fundamentals will not take into account other important factors: RenovaCare Total Value Analysis
RenovaCare is at this time forecasted to have valuation of 3.42 M with market capitalization of 29.7 M, debt of 800 K, and cash on hands of 243.96 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the RenovaCare fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.42 M | 29.7 M | 800 K | 243.96 K |
RenovaCare Asset Utilization
One of the ways to look at asset utilization of RenovaCare is to check how much profit was generated for every dollar of assets it reports. RenovaCare holds a negative application of assets of -1.04 pct., losing $0.0104 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of RenovaCare shows how discouraging it operates for each dollar spent on its assets.RenovaCare Ownership Allocation
RenovaCare owns a total of 87.35 Million outstanding shares. RenovaCare holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.18 pct. of RenovaCare outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.RenovaCare Profitability Analysis
Net Loss for the year was (4.47 M) with profit before overhead, payroll, taxes, and interest of 0.About RenovaCare Valuation
The pink sheet valuation mechanism determines RenovaCare's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of RenovaCare based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of RenovaCare. We calculate exposure to RenovaCare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of RenovaCare's related companies.RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. Renovacare operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct RenovaCare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates RenovaCare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct RenovaCare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain RenovaCare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine RenovaCare's revenue streams: Identify RenovaCare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research RenovaCare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish RenovaCare's growth potential: Evaluate RenovaCare's management, business model, and growth potential.
- Determine RenovaCare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate RenovaCare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
RenovaCare Growth Indicators
Investing in growth stocks can be very risky. If the company such as RenovaCare does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 87.4 M | |
| Retained Earnings | -34.2 M |
Additional Tools for RenovaCare Pink Sheet Analysis
When running RenovaCare's price analysis, check to measure RenovaCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovaCare is operating at the current time. Most of RenovaCare's value examination focuses on studying past and present price action to predict the probability of RenovaCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovaCare's price. Additionally, you may evaluate how the addition of RenovaCare to your portfolios can decrease your overall portfolio volatility.